# Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer

> **NCT06149767** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Fujian Cancer Hospital** · enrollment: 26 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** Adebrelimab

## Key facts

- **NCT ID:** NCT06149767
- **Lead sponsor:** Fujian Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-01
- **Primary completion:** 2028-02
- **Final completion:** 2028-03
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2023-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06149767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06149767, "Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT06149767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*